Sam Murphy
Directeur/Membre du Conseil chez VIRACTA THERAPEUTICS, INC.
Fortune : - $ au 31/05/2024
Profil
Sam Murphy is currently the Chief Executive Officer at Salubris Biotherapeutics, Inc. and Chairman at Go Therapeutics, Inc. He is also a Director at Viracta Subsidiary, Inc. and M.A.
Med Alliance SA, as well as an Independent Director at Viracta Therapeutics, Inc. In the past, he worked as a Director at Sunesis Pharmaceuticals, Inc. and as VP & Head-International Business Development at Shenzhen Salubris Pharmaceuticals Co., Ltd.
Dr. Murphy received his undergraduate and doctorate degrees from the University of Pennsylvania.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 20/06/2024 | 0 ( -.--% ) | - $ | 31/05/2024 |
Postes actifs de Sam Murphy
| Sociétés | Poste | Début |
|---|---|---|
| VIRACTA THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/01/2019 |
Viracta Subsidiary, Inc.
 Viracta Subsidiary, Inc. BiotechnologyHealth Technology Viracta Subsidiary, Inc. engages in the development of proprietary viral gene activation therapy to address cancers associated with the Epstein-Barr virus. Its platform is designed as a targeted approach to treat a range of viral-associated cancers and other serious diseases. The company was founded by Ronald J. Berenson, Douglas V. Faller, George C. Hillman, Thalia Papayannopoulou, Susan P. Perrine, George Stamatoyannopoulos, and Robert Williams and is headquartered in Cardiff, CA. | Directeur/Membre du Conseil | 01/01/2019 |
Go Therapeutics, Inc.
 Go Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Go Therapeutics, Inc. manufactures and develops cancer therapeutics. The company was founded by Constantine Theodoropulos and is headquartered in Cambrige, MA. | Président | - |
Salubris Biotherapeutics, Inc.
 Salubris Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Salubris Biotherapeutics, Inc. is a company that specializes in innovative drug discovery and development. The company is based in Gaithersburg, MD. The company is passionate, committed, and enthusiastic about their work, and value teamwork. The company was founded in 2016. Sam Murphy has been the CEO of the company since 2017. | Directeur Général | 01/11/2020 |
M.A. Med Alliance SA
 M.A. Med Alliance SA Packaged SoftwareTechnology Services M.A. Med Alliance SA is a company based in Nyon, Switzerland that specializes in developing innovative technology and commercializing advanced drug device combination products for the treatment of coronary and peripheral artery disease. The Swiss company's flagship product is the Selution SLR™ DEB, which is a novel sirolimus-eluting balloon platform technology. The CEO of the company is Jeffrey Bryan Jump. | Directeur/Membre du Conseil | 01/06/2016 |
Anciens postes connus de Sam Murphy
| Sociétés | Poste | Fin |
|---|---|---|
| SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD. | Corporate Officer/Principal | - |
| VIRACTA THERAPEUTICS, INC. | Directeur/Membre du Conseil | - |
Formation de Sam Murphy
| University of Pennsylvania | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD. | Health Technology |
| VIRACTA THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 5 |
|---|---|
Sunesis Pharmaceuticals, Inc.
 Sunesis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sunesis Pharmaceuticals, Inc. engages in the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers. The firm's activities include conducting research and development internally and through corporate collaborators, in-licensing and out-licensing pharmaceutical compounds and technology, conducting clinical trials and raising capital. The company was founded on February 10, 1998 and is headquartered in South San Francisco, CA. | Health Technology |
Viracta Subsidiary, Inc.
Viracta Subsidiary, Inc. BiotechnologyHealth Technology Viracta Subsidiary, Inc. engages in the development of proprietary viral gene activation therapy to address cancers associated with the Epstein-Barr virus. Its platform is designed as a targeted approach to treat a range of viral-associated cancers and other serious diseases. The company was founded by Ronald J. Berenson, Douglas V. Faller, George C. Hillman, Thalia Papayannopoulou, Susan P. Perrine, George Stamatoyannopoulos, and Robert Williams and is headquartered in Cardiff, CA. | Health Technology |
Go Therapeutics, Inc.
Go Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Go Therapeutics, Inc. manufactures and develops cancer therapeutics. The company was founded by Constantine Theodoropulos and is headquartered in Cambrige, MA. | Health Technology |
M.A. Med Alliance SA
M.A. Med Alliance SA Packaged SoftwareTechnology Services M.A. Med Alliance SA is a company based in Nyon, Switzerland that specializes in developing innovative technology and commercializing advanced drug device combination products for the treatment of coronary and peripheral artery disease. The Swiss company's flagship product is the Selution SLR™ DEB, which is a novel sirolimus-eluting balloon platform technology. The CEO of the company is Jeffrey Bryan Jump. | Technology Services |
Salubris Biotherapeutics, Inc.
Salubris Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Salubris Biotherapeutics, Inc. is a company that specializes in innovative drug discovery and development. The company is based in Gaithersburg, MD. The company is passionate, committed, and enthusiastic about their work, and value teamwork. The company was founded in 2016. Sam Murphy has been the CEO of the company since 2017. | Health Technology |
